GloWellness

IMPORTANT SAFETY INFORMATION

Last updated: August 2026

The following information is provided for educational purposes only. It does not replace the individualized guidance of your licensed healthcare provider. GloWellness does not practice medicine, prescribe medications, or make clinical decisions. All prescribing decisions are made solely by independent licensed providers.

Prescription medications are only dispensed following a medical evaluation and the issuance of a valid prescription by a licensed provider. Not all patients will qualify. Results vary by individual.

Compounded Tirzepatide & Compounded Semaglutide (GLP-1 Medications)

Do not use GLP-1 medications if you or a family member have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Disclose all medical conditions, medications, and supplements on your intake form before starting treatment.

Common side effects may include nausea, vomiting, diarrhea, constipation, and reduced appetite. These are generally mild and tend to improve over time.

Compounded GLP-1 medications are not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality. These medications are prepared based on individual patient need by state-licensed, FDA-registered compounding pharmacies.

GHK-Cu Copper Peptide

GHK-Cu is considered an experimental wellness therapy. It is not FDA-approved for the treatment, prevention, or cure of any medical condition. It is offered only through licensed compounding pharmacies following provider evaluation.

GHK-Cu therapies should not be used during pregnancy or while nursing. Due to potential influence on cell growth pathways, GHK-Cu is contraindicated in individuals with active cancer or a history of malignancy within the past five years unless cleared by a specialist.

Sermorelin

Sermorelin is prescribed off-label for adult growth hormone support. It is not recommended for individuals with active malignancy. Do not use during pregnancy or while breastfeeding without explicit guidance from your healthcare provider.

Common side effects may include mild discomfort at the injection site, water retention, and joint stiffness early in treatment. Disclose all medications and medical conditions on your intake form before starting.

NAD+

NAD+ injections are generally well-tolerated. Some individuals may experience mild discomfort, warmth, or flushing near the injection site. NAD+ is not FDA-approved to treat or prevent any specific condition.

Disclose all current medications, supplements, and health conditions on your intake form before starting.

General Disclaimers

Compounded medications are not FDA-approved and have not been reviewed for safety, effectiveness, or quality.

Prescription required. All medications are dispensed only pursuant to a valid prescription issued by a licensed provider following a medical evaluation.

GloWellness does not manufacture, compound, or dispense medications. GloWellness connects patients with independent licensed providers and state-licensed compounding pharmacies.

Results may vary. Individual outcomes depend on health profile, adherence to protocol, and other factors outside GloWellness's control.

If you experience a medical emergency, call 911 or go to the nearest emergency room immediately. Do not use GloWellness services for emergency care.

Back to top